Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease von Boulman, N., Levy, Y., Leiba, R., Shachar, S., Linn, R., Zinder, O., Blumenfeld, Z.

Volltext

Calcinosis in Rheumatic Diseases von Boulman, Nina, Slobodin, Gleb, Rozenbaum, Michael, Rosner, Itzhak

Volltext

AB0931 Anti-TNF Agents in Intractable Familial Mediterranean Fever with Axial Spondylarthropathy: Four Cases von Rozenbaum, M., Kaly, L., Rimar, D., Slobodin, G., Boulman, N., Jiries, N., Rosner, I.

Volltext

FRI0244 Lysyl Oxidase as A Biomarker in Systemic Sclerosis– A Multicenter Study von Rimar, D., Balbir Gurman, A., Meroni, P., Farge, D., Levy, Y., Rosner, I., Slobodin, G., Jiries, N., Rozenbaum, M., Kaly, L., Boulman, N., Zilber, K., Ginsberg, S., Awisat, A., Vadasz, Z.

Volltext

AB0539 Tofacitinib for Polyarteritis Nodosa – A Tailored Therapy von Rimar, D., Alpert, A., Starosvetsky, E., Rosner, I., Slobodin, G., Rozenbaum, M., Kaly, L., Boulman, N., Awisat, A., Shen Orr, S.S.

Volltext

Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis von Toubi, E, Kessel, A, Slobodin, G, Boulman, N, Pavlotzky, E, Zisman, D, Rozenbaum, M, Rosner, I

Volltext

AB0195 Semaphorin 3A as A Possible Immunoregulator in Systemic Sclerosis von Rimar, D., Rosner, I., Slobodin, G., Boulman, N., Rozenbaum, M., Halasz, K., Haj, T., Jiries, N., Kaly, L., Vadasz, Z.

Volltext

AB0141 Lysyl oxidase is correlated with fibrosis in systemic sclerosis von Rimar, D., Rosner, I., Slobodin, G., Rozenbaum, M., haj, T., Jiries, N., Kaly, L., Boulman, N., Vadas, Z.

Volltext

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy von Rosner, I., Haddad, A., Boulman, N., Feld, J., Avshovich, N., Slobodin, G., Rozenbaum, M.

Volltext

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever von Rimar, D, Rosner, I, Slobodin, G, Boulman, N, Kaly, L, Rozenbaum, M, Vadasz, Z

Volltext

Anti-tumor necrosis factor treatment and pregnancy: the way is open von Boulman, N, Rimar, D, Rozenbaum, M, Slobodin, G, Younis, S, Rosner, I

Volltext

Aortic involvement in rheumatic diseases von SLOBODIN, G, NASCHITZ, J. E, ZUCKERMAN, E, ZISMAN, D, ROZENBAUM, M, BOULMAN, N, ROSNER, I

Volltext

The role of regulatory T cells in familial Mediterranean fever (FMF) von Rimar, D., Rosner, I., Slobodin, G., Boulman, N., Toubi, E., Kessel, A., Peri, R., Rozenbaum, M.

Volltext

Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis von Boulman, N, Rozenbaum, M, Slobodin, G, Rosner, I

Volltext

Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine von Rozenbaum, M, Boulman, N, Feld, J, Avshovich, N, Petrovich, S, Elias, M, Slobodin, G, Rosner, I

Volltext

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-  therapy von Rosner, I., Haddad, A., Boulman, N., Feld, J., Avshovich, N., Slobodin, G., Rozenbaum, M.

Volltext

High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol von Blumenfeld, Z., Boulman, N., Leiba, R., Siegler, E., Shachar, S., Linn, R., Levy, Y.

Volltext

Semaphorin 3A, a potential immune regulator in familial Mediterranean fever von Rimar, Doron, Rosner, Itzhak, Slobodin, Gleb, Rozenbaum, Michael, Halasz, Katy, Jiries, Nizar, Kaly, Lisa, Boulman, Nina, Vadasz, Zahava

Volltext

P01-009 – 2 years of colchicine IV in intractable FMF von Kaly, L, Boulman, N, Rimar, D, Slobodin, G, Rosner, I, Rozenbaum, M

Volltext

Peridental mass in a patient with Forestier's/DISH von Boulman, Nina, Rosner, Itzhak, Slobodin, Gleb, Avshovich, Nina, Feld, Joy, Zeina, Abdel-Rauf, Rozenbaum, Michael

Volltext